https://doi.org/10.4081/ecj.2026.14658
Fixed vs. incremental shock energy for atrial fibrillation: electrical cardioversion strategies in the emergency department
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 16 February 2026
The optimal strategy for Electrical Cardioversion (ECV) in Atrial Fibrillation (AF) remains debated. We evaluated the impact of shock energy protocols on ECV outcomes in the Emergency Department (ED). This retrospective observational study included patients presenting with AF to the EDs in Trieste between January 2024 and April 2025. Patients undergoing ECV were classified according to initial shock energy: <200 J (incremental) or ≥200 J (fixed). Among 350 patients, overall ECV success was 92.6%, with 88.6% restoring sinus rhythm after the first shock. No significant difference in overall success was observed between incremental and fixed strategies (91.4% vs. 90.3%), although incremental energy achieved more first-shock conversions (88.1% vs. 77.4%). Magnesium sulphate premedication showed no significant association with ECV success (87.5% in patients who received magnesium vs. 93.2% in those who did not). Beta-blocker premedication was associated with lower success compared with no premedication (80% vs. 94.5%). Higher C-reactive protein levels were linked to failed cardioversion. These findings support individualized ECV strategies in the ED, with clinical judgment guiding energy selection and adjunctive therapies.
Downloads
1. Bizhanov KA, Аbzaliyev KB, Baimbetov AK, et al E. Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review). J Cardiovasc Electrophysiol 2023;34:153-65. DOI: https://doi.org/10.1111/jce.15759
2. Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2013;167:1807–24. DOI: https://doi.org/10.1016/j.ijcard.2012.12.093
3. Caldarola P, De Iaco F, Pugliese FR, et al. Documento di consenso ANMCO-SIMEU: Gestione appropriata della fibrillazione atriale in Pronto Soccorso [ANMCO-SIMEU Consensus document: Appropriate management of atrial fibrillation in the emergency department]. G Ital Cardiol (Rome) 2023;24:136–59. DOI: https://doi.org/10.1714/3963.39422
4. Nusair M, Flaker GC, Chockalingam A. Electric cardioversion of atrial fibrillation. Mo Med 2010;107:59–64.
5. Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41–6. DOI: https://doi.org/10.1016/0002-9149(91)90707-R
6. Inácio JFS, Rosa M dos SG da, Shah J, et al. Monophasic and biphasic shock for transthoracic conversion of atrial fibrillation: Systematic review and network meta-analysis. Resuscitation 2016;100:66–75. DOI: https://doi.org/10.1016/j.resuscitation.2015.12.009
7. Nguyen ST, Belley-Côté EP, Ibrahim O, et al. Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis. Europace 2023;25:318–30. DOI: https://doi.org/10.1093/europace/euac199
8. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024;45:3314–414. DOI: https://doi.org/10.1093/eurheartj/ehae176
9. Schmidt AS, Lauridsen KG, Torp P, et al. Maximum-fixed energy shocks for cardioverting atrial fibrillation. Eur Heart J 2020;41:626–31. DOI: https://doi.org/10.1093/eurheartj/ehz585
10. Glover BM, Walsh SJ, McCann CJ, et al. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart 2008;94:884–7. DOI: https://doi.org/10.1136/hrt.2007.120782
11. Sultan A, Steven D, Rostock T, et al. Intravenous administration of magnesium and potassium solution lowers energy levels and increases success rates electrically cardioverting atrial fibrillation. J Cardiovasc Electrophysiol 2012;23:54–9. DOI: https://doi.org/10.1111/j.1540-8167.2011.02146.x
12. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med 2005;45:347–53. DOI: https://doi.org/10.1016/j.annemergmed.2004.09.013
13. Rajagopalan B, Shah Z, Narasimha D, et al. Efficacy of Intravenous Magnesium in Facilitating Cardioversion of Atrial Fibrillation. Circ Arrhythm Electrophysiol 2016;9:e003968. DOI: https://doi.org/10.1161/CIRCEP.116.003968
14. Ramesh T, Lee PYK, Mitta M, Allencherril J. Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis. J Cardiol 2021;78:375–81. DOI: https://doi.org/10.1016/j.jjcc.2021.06.001
15. Gilardi E, Pomero F, Ravera E, et al. Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care. JCM 2022;11:5527. DOI: https://doi.org/10.3390/jcm11195527
16. Climent VE, Marin F, Mainar L, et al. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol PACE 2004;27:368–72. DOI: https://doi.org/10.1111/j.1540-8159.2004.00444.x
17. Kuipers S, Klouwenberg PMK, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care 2014;18:688. DOI: https://doi.org/10.1186/s13054-014-0688-5
CRediT authorship contribution
Conceptualization Nicola Artusi, Elena Caliandro, Francesca Carrozzo; methodology Nicola Artusi, Francesca Carrozzo; data collection and investigation Giulia Barbante, Elena Caliandro; formal analysis Nicola Artusi, Giulia Barbante, Ugo Giulio Sisto; writing: original draft Giulia Barbante; writing: review and editing Nicola Artusi, Ugo Giulio Sisto; supervision Nicola Artusi. All authors approved the final manuscript.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
